The University of Southampton
University of Southampton Institutional Repository

Cohort profile: post-hospitalisation COVID-19 (PHOSP-COVID) study

Cohort profile: post-hospitalisation COVID-19 (PHOSP-COVID) study
Cohort profile: post-hospitalisation COVID-19 (PHOSP-COVID) study
The Post-Hospitalisation COVID-19 (PHOSP-COVID) study is a national UK multicentre cohort study of patients who were hospitalized for COVID-19 and subsequently discharged.

PHOSP-COVID was established to investigate the medium- and long-term sequelae of severe COVID-19 requiring hospitalization, understand the underlying mechanisms of these sequelae, evaluate the medium- and long-term effects of COVID-19 treatments and to serve as a platform to enable future studies, including clinical trials.

Data collected covered a wide range of physical measures, biological samples and patient-reported outcome measures (PROMs).

Participants could join the cohort either in Tier 1 only with remote data collection using hospital records, a PROMs app and postal saliva sample for DNA; or in Tier 2 in which they were invited to attend two specific research visits for further data collection and biological research sampling. These research visits occurred at 5 (range 2–7) months and 12 (range 10–14) months post-discharge. Participants could also participate in specific nested studies (Tier 3) at selected sites.
All participants were asked to consent to further follow-up for 25 years via linkage to their electronic healthcare records and to be re-contacted for further research.

In total, 7935 participants were recruited from 83 UK sites: 5238 to Tier 1 and 2697 to Tier 2, between August 2020 and March 2022.

Cohort data are held in a Trusted Research Environment and samples stored in a central biobank. Data and samples can be accessed upon request and subject to approvals from https://www.phosp.org/data-sample-request/.
0300-5771
Elneima, Omer
f63465fa-6af2-4346-809d-248160659e7b
McAuley, Hamish J.C.
7c7abd53-d2be-45f8-bc82-a5bb727f5945
Leavy, Olivia C.
31fedd8a-9d66-42a3-bf92-0ea370a8aaee
Jones, Mark G.
a6fd492e-058e-4e84-a486-34c6035429c1
et al.
on Behalf of the PHOSP-COVID Collaborative Group
Elneima, Omer
f63465fa-6af2-4346-809d-248160659e7b
McAuley, Hamish J.C.
7c7abd53-d2be-45f8-bc82-a5bb727f5945
Leavy, Olivia C.
31fedd8a-9d66-42a3-bf92-0ea370a8aaee
Jones, Mark G.
a6fd492e-058e-4e84-a486-34c6035429c1

Elneima, Omer, McAuley, Hamish J.C. and Leavy, Olivia C. , et al. and on Behalf of the PHOSP-COVID Collaborative Group (2023) Cohort profile: post-hospitalisation COVID-19 (PHOSP-COVID) study. International Journal of Epidemiology. (doi:10.1093/ije/dyad165).

Record type: Article

Abstract

The Post-Hospitalisation COVID-19 (PHOSP-COVID) study is a national UK multicentre cohort study of patients who were hospitalized for COVID-19 and subsequently discharged.

PHOSP-COVID was established to investigate the medium- and long-term sequelae of severe COVID-19 requiring hospitalization, understand the underlying mechanisms of these sequelae, evaluate the medium- and long-term effects of COVID-19 treatments and to serve as a platform to enable future studies, including clinical trials.

Data collected covered a wide range of physical measures, biological samples and patient-reported outcome measures (PROMs).

Participants could join the cohort either in Tier 1 only with remote data collection using hospital records, a PROMs app and postal saliva sample for DNA; or in Tier 2 in which they were invited to attend two specific research visits for further data collection and biological research sampling. These research visits occurred at 5 (range 2–7) months and 12 (range 10–14) months post-discharge. Participants could also participate in specific nested studies (Tier 3) at selected sites.
All participants were asked to consent to further follow-up for 25 years via linkage to their electronic healthcare records and to be re-contacted for further research.

In total, 7935 participants were recruited from 83 UK sites: 5238 to Tier 1 and 2697 to Tier 2, between August 2020 and March 2022.

Cohort data are held in a Trusted Research Environment and samples stored in a central biobank. Data and samples can be accessed upon request and subject to approvals from https://www.phosp.org/data-sample-request/.

Text
dyad165 - Version of Record
Available under License Creative Commons Attribution.
Download (1MB)

More information

Accepted/In Press date: 7 December 2023
e-pub ahead of print date: 18 December 2023
Additional Information: For the purpose of open access, the author has applied a CC-BY public copyright licence to any author accepted manuscript version arising from this submission.

Identifiers

Local EPrints ID: 486270
URI: http://eprints.soton.ac.uk/id/eprint/486270
ISSN: 0300-5771
PURE UUID: 61f225db-eb05-42a9-be82-7af1cfce0156
ORCID for Mark G. Jones: ORCID iD orcid.org/0000-0001-6308-6014

Catalogue record

Date deposited: 16 Jan 2024 17:40
Last modified: 18 Mar 2024 03:07

Export record

Altmetrics

Contributors

Author: Omer Elneima
Author: Hamish J.C. McAuley
Author: Olivia C. Leavy
Author: Mark G. Jones ORCID iD
Corporate Author: et al.
Corporate Author: on Behalf of the PHOSP-COVID Collaborative Group

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×